drugset / Trial / NCT00192842
Gemcitabine With Curcumin for Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study hypotheasis is that curcumin, a natural compound with a potent antiproliferative effect, can improve the efficacy of the standard chemotherapy gemcitabine in patients with advanced pancreatic cancer. That is why the patients are given a daily oral dose of 8 gr of curcumin along the chemotherapeutic protocol of weekly gemcitabine.
Timeline
- Start
- 2004-07
- Primary completion
- 2007-11
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 8 g | Oral |
| Background | Gemcitabine | Small molecule | — | — |